MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-02-0010940
Galipea Molecules Private Limited
Galipea Molecules Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹68.24 Lakh
▲ 112% YoY
Net loss · FY 2024
₹13.24 Lakh
Net margin -19.4%
EBITDA · FY 2024
-₹12.86 Lakh
EBITDA margin -18.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Galipea Molecules Private Limited
Data last updated:
Galipea Molecules Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 June 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2019PTC351484. Its GSTIN is 10AAHCG8704H1ZV (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rameshwar Kumar and Srishti Shaumya.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at House No. – 44 – C – 2C Janakpuri P & T Colony, New Delhi, Delhi, India – 110058.
As per the financials filed for FY 2024, the company reported a revenue of ₹68.24 Lakh, a growth of 112% compared to the previous year. For the same year it recorded a net loss of ₹13.24 Lakh (net margin -19.4%) and EBITDA of -₹12.86 Lakh (EBITDA margin -18.8%). Revenue has grown at a compounded annual rate (CAGR) of 45% over three years.
The company is associated with 1 brand: Galipea.
Galipea Molecules Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0010940).
Company details
CIN U24299DL2019PTC351484
Registration Number 351484
Incorporation Date 18 June 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Micro
Udyam Registration UDYAM-DL-02-0010940
Key People
Rameshwar Kumar Director Srishti Shaumya Director Recognitions & Rankings of Galipea Molecules
Contact details
Galipea Molecules Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No. – 44 – C – 2C Janakpuri P & T Colony, New Delhi, Delhi, India – 110058
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Galipea Molecules Private Limited, buy the company report.
Comprehensive company report
Galipea Molecules Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Galipea Molecules operates one associated brand: Galipea. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical product manufacturing and marketing in India. | galipea.in |
Business activity
The main business activity of Galipea Molecules is hospital and medical care. In detail, this covers hospital activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities |
To see the full business activity and turnover split of Galipea Molecules Private Limited, buy the company report.
Financials of Galipea Molecules Private Limited
FY 2024 filings availableGalipea Molecules Private Limited reported revenue of ₹68.24 Lakh (up 112% YoY) for FY 2024.
Revenue · FY 2024
₹68.24 Lakh ▲ 112%
Net loss · FY 2024
₹13.24 Lakh margin -19.4%
EBITDA · FY 2024
-₹12.86 Lakh margin -18.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 112%
3 years · compounded
▲ 45%
EBITDA CAGR growth
1 year
▲ 54%
3 years · compounded
▲ 21%
Revenue has grown at a compounded annual rate (CAGR) of 45% over three years, including 112% growth in the latest year. EBITDA rose 54% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹12.86 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹13.24 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -18.8% | ||||
| Net Profit Margin | -19.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Galipea Molecules Private Limited, buy the company report.
Board of directors of Galipea Molecules Private Limited
Galipea Molecules has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rameshwar Kumar | Director | 18 Jun 2019 | 7 Years 4 Months | Current |
| Srishti Shaumya | Director | 18 Feb 2022 | 4 Years 8 Months | Current |
Peer comparison
Galipea Molecules Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (hospital activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nobel Rural Hospital Private Limited | ₹68.56 Lakh (FY 2024) | 6.0% | Patna, Bihar, India | |||
| Sarjan Multi Speciality Hospital Private Limited | ₹68.54 Lakh (FY 2024) | 107.0% | Ahmedabad, Gujarat, India | |||
| Dr Manseta Ent Hospital Private Limited | ₹68.43 Lakh (FY 2025) | -10.0% | Ahmedabad, Gujarat, India | |||
| Lakshmi Organised Care & United Services Private Limited | ₹68.43 Lakh (FY 2024) | 63.0% | Chennai, Tamil Nadu, India | |||
| Supermax Healthcare Private Limited | ₹68.31 Lakh (FY 2024) | 11.0% | Moradabad, Uttar Pradesh, India | |||
| Galipea Molecules Private Limitedthis company | ₹68.24 Lakh (FY 2024) | -₹13.24 Lakh | -19.4% | 112.0% | New Delhi, Delhi, India | |
| Prekesh Healthcare Private Limited | ₹68.21 Lakh (FY 2025) | -10.0% | Paliya, Uttar Pradesh, India | |||
| Narayan Multi-Speciality Healthcare Private Limited | ₹67.97 Lakh (FY 2025) | 3.0% | Taluka-Kalyan, Maharashtra, India | |||
| Kand Medi Square Health Services Private Limited | ₹67.95 Lakh (FY 2023) | 6.0% | Pune, Maharashtra, India | |||
| 3H Hospitals Private Limited | ₹67.84 Lakh (FY 2024) | 48.0% | Cuttack, Odisha, India | |||
| Jeevan Raksha Hospital Private Limited | ₹67.51 Lakh (FY 2025) | 107.0% | Dungarpur, Rajasthan, India |
To see the full peer comparison of Galipea Molecules Private Limited, buy the company report.
Auditor
Galipea Molecules Private Limited is audited by N KANTAN & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N KANTAN & ASSOCIATES | FY 2021 | 014757C |
Shareholding
The shareholding of Galipea Molecules Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Galipea Molecules Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Galipea Molecules Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Galipea Molecules Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Galipea Molecules has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAHCG8704H1ZV | Bihar | Active | 23 Jun 2019 |
To see the full GST registrations and return filing status of Galipea Molecules Private Limited, buy the company report.
Recent activity
Galipea Molecules Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Srishti Shaumya was appointed as Director on 18 Feb 2022.
AGM
Galipea Molecules Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Galipea Molecules Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi I.
Appointed
Srishti Shaumya was appointed as Director.
Ceased
Utpal Kumar ceased to be Director.
Appointed
Rameshwar Kumar was appointed as Director.
Incorporation
18 Jun 2019
Galipea Molecules Private Limited was registered on 18 Jun 2019 with Roc Delhi I & aged 7 years 4 months as per MCA records.
Frequently asked questions
Galipea Molecules is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 June 2019 (7+ years old) and is registered under CIN U24299DL2019PTC351484.
Galipea Molecules has 2 current directors:
- Rameshwar Kumar - Director
- Srishti Shaumya - Director
The latest financial statements of Galipea Molecules on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Galipea Molecules is 10AAHCG8704H1ZV, registered in Bihar.
The CIN (Corporate Identification Number) of Galipea Molecules is U24299DL2019PTC351484. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Galipea Molecules was incorporated on 18 June 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Galipea Molecules by revenue are Nobel Rural Hospital Private Limited, Sarjan Multi Speciality Hospital Private Limited, Dr Manseta Ent Hospital Private Limited, Lakshmi Organised Care & United Services Private Limited, Supermax Healthcare Private Limited and 5 more, all in the same principal business activity (hospital activities).
Srishti Shaumya was appointed as Director on 18 Feb 2022. Utpal Kumar ceased to be Director on 18 Feb 2022. Rameshwar Kumar was appointed as Director on 18 Jun 2019.
Yes, Galipea Molecules is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0010940).
The registered office of Galipea Molecules is at House No. – 44 – C – 2C Janakpuri P & T Colony, New Delhi, Delhi, India – 110058.
Galipea Molecules operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages